On the public citation graph

The survival benefit of liver transplantation in hepatocellular carcinoma patients

https://doi.org/10.1016/j.dld.2010.02.010
0 signed · 77 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/hep.20933openalex-snapshot
Management of Hepatocellular Carcinoma *
inferredcites →https://doi.org/10.1002/lt.20837openalex-snapshot
Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/lt.21033openalex-snapshot
Response to Preoperative Chemoembolization Correlates with Outcome After Liver Transplantation in Patients with Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1002/lt.21095openalex-snapshot
Expanded Criteria for Liver Transplantation in Patients with Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1016/0002-9343(82)90786-0openalex-snapshot
A convenient approximation of life expectancy (the “DEALE”)
inferredcites →https://doi.org/10.1016/j.cld.2007.04.005openalex-snapshot
The Model for End-stage Liver Disease Comes of Age
inferredcites →https://doi.org/10.1016/j.jhep.2005.10.013openalex-snapshot
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
inferredcites →https://doi.org/10.1016/j.transproceed.2009.03.053openalex-snapshot
Prospective Validation of a New Priority Allocation Model for Liver Transplant Candidates: An Interim Analysis
inferredcites →https://doi.org/10.1016/s0168-8278(01)00130-1openalex-snapshot
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
inferredcites →https://doi.org/10.1016/s1470-2045(08)70284-5openalex-snapshot
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
inferredcites →https://doi.org/10.1053/he.2000.5763openalex-snapshot
Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: An outcome-oriented decision analysis
inferredcites →https://doi.org/10.1053/j.gastro.2008.02.013openalex-snapshot
Liver Transplantation for Hepatocellular Carcinoma: Impact of the MELD Allocation System and Predictors of Survival
inferredcites →https://doi.org/10.1053/j.gastro.2008.03.042openalex-snapshot
Liver Transplantation for Hepatocellular Carcinoma: Who Benefits and Who Is Harmed?
inferredcites →https://doi.org/10.1053/jhep.2001.23311openalex-snapshot
Living Donor Liver Transplantation for Early Hepatocellular Carcinoma: A Life–Expectancy and Cost–Effectiveness Perspective
inferredcites →https://doi.org/10.1056/nejm199603143341104openalex-snapshot
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
inferredcites →https://doi.org/10.1056/nejmoa0801209openalex-snapshot
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
inferredcites →https://doi.org/10.1093/jjco/hyg093openalex-snapshot
Measuring Response in Solid Tumors: Comparison of RECIST and WHO Response Criteria
inferredcites →https://doi.org/10.1097/01.sla.0000109146.72827.76openalex-snapshot
Liver Transplantation for the Treatment of Moderately or Well-Differentiated Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1111/j.1600-6143.2004.00703.xopenalex-snapshot
The Survival Benefit of Liver Transplantation
inferredcites →https://doi.org/10.1111/j.1600-6143.2006.01321.xopenalex-snapshot
Waiting List Removal Rates Among Patients with Chronic and Malignant Liver Diseases
inferredcites →https://doi.org/10.1111/j.1600-6143.2006.01719.xopenalex-snapshot
Intention-to-Treat Analysis of Liver Transplantation in Selected, Aggressively Treated HCC Patients Exceeding the Milan Criteria
inferredcites →https://doi.org/10.1111/j.1600-6143.2007.02086.xopenalex-snapshot
The Survival Benefit of Deceased Donor Liver Transplantation as a Function of Candidate Disease Severity and Donor Quality
inferredcites →https://doi.org/10.1111/j.1600-6143.2007.02138.xopenalex-snapshot
A Novel Model Measuring the Harm of Transplanting Hepatocellular Carcinoma Exceeding Milan Criteria
inferredcites →https://doi.org/10.1111/j.1600-6143.2009.02571.xopenalex-snapshot
Survival Benefit-Based Deceased-Donor Liver Allocation
inferredcites →https://doi.org/10.1177/0272989x08316999openalex-snapshot
Beyond Utilitarianism: A Method for Analyzing Competing Ethical Principles in a Decision Analysis of Liver Transplantation

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4663331openalex-extracted
The Survival Benefit of Liver Transplantation for Metabolic Associated Steatotic Liver Disease: An Italian Liver Transplant Registry Study
inferred← citeshttps://doi.org/10.1001/jamasurg.2024.3928openalex-snapshot
Methods and Statistical Analysis in a Study of Liver Resection vs Nonsurgical Treatments for Hepatocellular Carcinoma—Reply
inferred← citeshttps://doi.org/10.1002/hep.28998openalex-snapshot
Liver transplantation for hepatocellular carcinoma through the lens of transplant benefit
inferred← citeshttps://doi.org/10.1002/jhbp.1248openalex-snapshot
Bridging therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta‐analysis on intention‐to‐treat outcomes
inferred← citeshttps://doi.org/10.1002/lt.23706openalex-snapshot
Alpha-fetoprotein and modified response evaluation criteria in Solid Tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation
inferred← citeshttps://doi.org/10.1002/lt.24082openalex-snapshot
Urgency, utility, and time horizon of transplant benefit
inferred← citeshttps://doi.org/10.1002/lt.24214openalex-snapshot
Utility‐based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha‐fetoprotein model as a survival predictor
inferred← citeshttps://doi.org/10.1002/lt.24758openalex-snapshot
Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: An attempt to perform an ideal meta‐analysis
inferred← citeshttps://doi.org/10.1007/978-3-031-90225-3_17openalex-snapshot
Should Resection Be the Preferred Therapeutic Option for Patients Within the Milan Criteria and Compensated Cirrhosis Without Portal Hypertension?
inferred← citeshttps://doi.org/10.1007/s40472-016-0117-6openalex-snapshot
Liver-allocation policies for patients affected by HCC in Europe
inferred← citeshttps://doi.org/10.1016/j.dld.2010.07.001openalex-snapshot
“Survival benefit”: The final destination, with still a long way to go
inferred← citeshttps://doi.org/10.1016/j.dld.2012.01.018openalex-snapshot
What is the probability of being too old for salvage transplantation after hepatocellular carcinoma resection?
inferred← citeshttps://doi.org/10.1016/j.dld.2013.01.012openalex-snapshot
Position paper of the Italian Association for the Study of the Liver (AISF): The multidisciplinary clinical approach to hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.dld.2023.10.029openalex-snapshot
Multidisciplinary Treatment of Hepatocellular Carcinoma in 2023: Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of Hepato-Bilio-Pancreatic Surgery (AICEP), Italian Association…
inferred← citeshttps://doi.org/10.1016/j.dld.2024.12.003openalex-snapshot
Hepatocellular carcinoma: Revising the surgical approach in light of the concept of multiparametric therapeutic hierarchy
inferred← citeshttps://doi.org/10.1016/j.jhep.2013.10.010openalex-snapshot
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list
inferred← citeshttps://doi.org/10.1016/j.jhep.2014.01.022openalex-snapshot
Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on “number of patients needed to transplant” as measure of transplant benefit
inferred← citeshttps://doi.org/10.1016/j.jhepr.2024.101147openalex-snapshot
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study
inferred← citeshttps://doi.org/10.1016/j.trre.2023.100773openalex-snapshot
Rescue liver transplantation after post-hepatectomy acute liver failure: A systematic review and pooled analysis
inferred← citeshttps://doi.org/10.1016/s1470-2045(11)70144-9openalex-snapshot
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study
inferred← citeshttps://doi.org/10.1016/s1499-3872(16)60097-8openalex-snapshot
Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment
inferred← citeshttps://doi.org/10.1097/cld.0000000000000129openalex-snapshot
Proper assessment and prognostication of patients with hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1097/hc9.0000000000000619openalex-snapshot
Survival benefit associated with liver transplantation for hepatocellular carcinoma based on tumor burden scores at listing
inferred← citeshttps://doi.org/10.1111/ajt.12923openalex-snapshot
Toward a Better Liver Graft Allocation That Accounts for Candidates With and Without Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1111/ajt.13408openalex-snapshot
A Multistep, Consensus-Based Approach to Organ Allocation in Liver Transplantation: Toward a “Blended Principle Model”
inferred← citeshttps://doi.org/10.1111/j.1432-2277.2011.01276.xopenalex-snapshot
Comparison between observed survival after resection of transplantable hepatocellular carcinoma and predicted survival after listing through a Markov model simulation
inferred← citeshttps://doi.org/10.1111/j.1432-2277.2011.01423.xopenalex-snapshot
http://www.D-MELD.com, the Italian survival calculator to optimize donor to recipient matching and to identify the unsustainable matches in liver transplantation
inferred← citeshttps://doi.org/10.1111/j.1600-6143.2011.03732.xopenalex-snapshot
Balancing Donor and Recipient Risk Factors in Liver Transplantation: The Value of D-MELD With Particular Reference to HCV Recipients
inferred← citeshttps://doi.org/10.1136/gutjnl-2021-324915openalex-snapshot
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA.LI.CA database
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-11-2663openalex-snapshot
Conditional Survival after Hepatic Resection for Hepatocellular Carcinoma in Cirrhotic Patients
inferred← citeshttps://doi.org/10.1159/000449344openalex-snapshot
Surgery and Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1159/000546360openalex-snapshot
THE CONCEPT OF “CONVERSE THERAPEUTIC HIERARCHY” FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA
inferred← citeshttps://doi.org/10.1245/s10434-014-4099-2openalex-snapshot
Survival Benefit of Liver Transplantation Versus Resection for Hepatocellular Carcinoma: Impact of MELD Score
inferred← citeshttps://doi.org/10.1371/journal.pone.0050919openalex-snapshot
The Survival Benefit of Liver Transplantation for Hepatocellular Carcinoma Patients with Hepatitis B Virus Infection and Cirrhosis
inferred← citeshttps://doi.org/10.17826/cumj.552485openalex-snapshot
Hepatosellüler karsinomada bridging veya downstaging sonrası karaciğer transplantasyonu ile direkt transplantasyon stratejilerinin sağkalım üzerine etkilerinin karşılaştırılması
inferred← citeshttps://doi.org/10.20517/2394-5079.2024.107openalex-snapshot
Hepatocellular carcinoma recurrence after liver transplantation: risk factors, targeted surveillance and management options
inferred← citeshttps://doi.org/10.21037/tgh.2017.09.04openalex-snapshot
Selection of patients with hepatocellular cancer: a difficult balancing between equity, utility, and benefit
inferred← citeshttps://doi.org/10.21614/chirurgia.112.3.208openalex-snapshot
The European Policy for Liver Allocation in Patients Affected by Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3389/fonc.2022.1101351openalex-snapshot
Efficacy and safety of transarterial chemoembolization plus sorafenib in patients with recurrent hepatocellular carcinoma after liver transplantation
inferred← citeshttps://doi.org/10.3389/fsurg.2021.693387openalex-snapshot
Colon Rectal Liver Metastases: The Role of the Liver Transplantation in the Era of the Transplant Oncology and Precision Medicine
inferred← citeshttps://doi.org/10.3390/cancers13040897openalex-snapshot
Surveillance as Determinant of Long-Term Survival in Non-Transplanted Hepatocellular Carcinoma Patients
inferred← citeshttps://doi.org/10.3390/cancers13061416openalex-snapshot
Liver Transplantation for T2 Hepatocellular Carcinoma during the COVID-19 Pandemic: A Novel Model Balancing Individual Benefit against Healthcare Resources
inferred← citeshttps://doi.org/10.3390/cancers13071673openalex-snapshot
Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC Classifications
inferred← citeshttps://doi.org/10.3390/cancers13102406openalex-snapshot
Sustained Complete Response after Biological Downstaging in Patients with Hepatocellular Carcinoma: XXL-Like Prioritization for Liver Transplantation or “Wait and See” Strategy?
inferred← citeshttps://doi.org/10.3390/cancers14205102openalex-snapshot
Downstaging Therapies for Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation: A Systematic Review and Meta-Analysis on Intention-to-Treat Outcomes
inferred← citeshttps://doi.org/10.3390/cancers15020436openalex-snapshot
Textbook Outcome of Laparoscopic Microwave Ablation for Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3390/cancers17132248openalex-snapshot
Laparoscopic Microwave Ablation and Salvage Liver Transplantation in Patients with Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3748/wjg.v19.i43.7515openalex-snapshot
Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation
inferred← citeshttps://doi.org/10.3748/wjg.v19.i44.8093openalex-snapshot
“Metroticket” predictor for assessing liver transplantation to treat hepatocellular carcinoma: A single-center analysis in mainland China
inferred← citeshttps://doi.org/10.3748/wjg.v19.i48.9183openalex-snapshot
Transplant benefit for patients with hepatocellular carcinoma
inferred← citeshttps://doi.org/10.3748/wjg.v20.i15.4141openalex-snapshot
Staging systems of hepatocellular carcinoma: A review of literature
inferred← citeshttps://doi.org/10.70675/b026b35az0950z4446zbcdaz6eec155c2e4fopenalex-snapshot
Facteurs pronostiques de survie du carcinome hépatocellulaire : approche épidémiologico-chirurgicale
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.